17-alpha-hydroxyprogesterone has been researched along with Recrudescence in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elovitz, MA; Levine, LD; Purisch, SE; Turitz, AL | 1 |
Cruz Ortiz, SG; Llorens, A; Pereira, OM; Rosa, ER | 1 |
Chen, L; Cheng, J; Huang, Y; Li, X; Liu, L; Lu, S; Xiao, Q; Xie, T; Zheng, J | 1 |
Bastek, JA; Elovitz, MA; Levine, LD; Purisch, SE; Turitz, AL | 1 |
Desch, CN; Istwan, NB; Joy, S; Rhea, DJ; Stanziano, G | 1 |
Iams, JD | 1 |
Carbonne, B; Rosenblatt, J | 1 |
Caritis, SN; Carpenter, M; Conway, D; Dombrowski, MP; Gabbe, S; Hauth, JC; Iams, JD; Leveno, KJ; Meis, PJ; Mercer, B; Miodovnik, M; Moawad, AH; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Sibai, B; Spong, CY; Thom, EA; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
Cleary-Goldman, J; Istwan, NB; Rebarber, A; Rhea, DJ; Russo-Stieglitz, K; Saltzman, DH; Stanziano, GJ | 1 |
Bailey, EM; Oliver, JW; Schneider, JF; Wagner, RA | 1 |
1 review(s) available for 17-alpha-hydroxyprogesterone and Recrudescence
Article | Year |
---|---|
[Prevention of recurrent preterm birth: a comeback for progesterone?].
Topics: 17-alpha-Hydroxyprogesterone; Female; Humans; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Recurrence; Risk Factors | 2005 |
9 other study(ies) available for 17-alpha-hydroxyprogesterone and Recrudescence
Article | Year |
---|---|
The Effect of Prior Term Birth on Risk of Recurrent Spontaneous Preterm Birth.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Birth Order; Female; Gestational Age; Humans; Infant, Newborn; Logistic Models; Multivariate Analysis; Pennsylvania; Pregnancy; Pregnancy Outcome; Premature Birth; Recurrence; Retrospective Studies; Risk Factors; Term Birth; Young Adult | 2018 |
Pregnancy and neonatal outcomes of women receiving compounded 17-alpha hydroxyprogesterone at San Juan City hospital.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Birth Weight; Drug Evaluation; Female; Gestational Age; Home Care Services, Hospital-Based; Humans; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Male; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Puerto Rico; Recurrence; Stillbirth; Tocolytic Agents; Urban Population | 2013 |
[A novel homozygous mutation p.E25X in the HSD3B2 gene causing salt wasting 3β-hydroxysteroid dehydrogenases deficiency in a Chinese pubertal girl: a delayed diagnosis until recurrent ovary cysts].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Androstenedione; China; Codon, Nonsense; Delayed Diagnosis; Female; Follicle Stimulating Hormone; Homozygote; Humans; Hydrocortisone; Luteinizing Hormone; Mutation; Ovarian Cysts; Progesterone Reductase; Recurrence; Retrospective Studies | 2014 |
Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Cerclage, Cervical; Cross-Sectional Studies; Female; Fetal Death; Humans; Patient Acceptance of Health Care; Pennsylvania; Pregnancy; Pregnancy, High-Risk; Premature Birth; Progestins; Recurrence | 2016 |
The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fetal Monitoring; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Probability; Recurrence; Retrospective Studies; Risk Assessment | 2010 |
Was the preterm birth rate in the placebo group too high in the Meis MFMU Network trial of 17-OHPC?
Topics: 17-alpha-Hydroxyprogesterone; Castor Oil; Female; Humans; Oxytocin; Pregnancy; Pregnancy Trimester, Third; Premature Birth; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Uterine Contraction | 2010 |
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
Topics: 17-alpha-Hydroxyprogesterone; Female; Gestational Age; Humans; Logistic Models; Pregnancy; Premature Birth; Proportional Hazards Models; Recurrence | 2005 |
Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Caproates; Diabetes, Gestational; Female; Humans; Incidence; Injections, Intramuscular; Pregnancy; Premature Birth; Recurrence; Tocolytic Agents | 2007 |
Leuprolide acetate treatment of adrenocortical disease in ferrets.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Diseases; Aggression; Androstenedione; Animals; Dehydroepiandrosterone Sulfate; Estradiol; Ferrets; Leuprolide; Recurrence; Safety; Sexual Behavior, Animal; Time Factors; Treatment Outcome | 2001 |